ResearcherUniversity of SienaActive in the last 2 years

Chiara Falciani

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0002-1027-8482; OpenAlex author ID A5084001430.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer. Last author DOI 10.3389/fmolb.2024.1429163 ↗
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer. Last author DOI 10.3389/fonc.2021.695858 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Simone Furini · 1 shared paper, 2021
- Paper Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer. DOI 10.3389/fonc.2021.695858 ↗
Alessandro Rencinai · 1 shared paper, 2024
- Paper Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immu… DOI 10.3389/fmolb.2024.1429163 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.